HopeStage
Back to all studies
CompletedNCT00129467

Methylphenidate for depression in palliative cancer care

About this titleRead the official source — NCT00129467
Medication studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
PortlandSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateFebruary 2005
Recruitment status
Completed
Enrollment listed in the registry
47
Sponsor
US Department of Veterans Affairs
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00129467
Official title
Show the full official title

Methylphenidate for Depressed Cancer Patients in Hospice

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Portland

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is US Department of Veterans Affairs.

Did this study involve medication?

Yes. The study involved medication, including Methylphenidate, Placebo and Selective Serotonin Uptake Inhibitor (SSRI).

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies